Friday, May 15, 2026 12:14:58 AM
RVPH delisted from the Nasdaq to the OTC
https://otce.finra.org/otce/dailyList?viewType=Additions
https://otce.finra.org/otce/dailyList?viewType=Additions
To bite the worm of incite is to bite the HOOK of the antagonist . They win .
Recent RVPH News
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 05/15/2026 01:25:59 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2026 08:43:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 08:41:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 12:03:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/15/2026 12:05:13 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/30/2026 01:02:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/30/2026 10:11:59 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2026 09:00:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2026 09:00:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/19/2026 08:17:46 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/19/2026 08:17:08 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/18/2026 08:09:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2026 01:00:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2026 09:15:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/23/2025 01:05:14 PM
- Reviva Pharmaceuticals shares tumble after $9M public offering priced • IH Market News • 09/19/2025 02:20:26 PM
